Sort   by:  
 Page size 
UnknownDrug therapy for advanced-stage liver cancer.
Not available
S-EPMC4057791 | biostudies-literature
UnknownReview article: systemic treatment of hepatocellular carcinoma.
Not available
S-EPMC6120553 | biostudies-literature
UnknownTime to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?-the SCOOP-2 trial experience.
Not available
S-EPMC7723635 | biostudies-literature
UnknownCancer and liver cirrhosis: implications on prognosis and management.
Not available
S-EPMC5070280 | biostudies-literature
UnknownThe Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
Not available
S-EPMC4658167 | biostudies-literature
UnknownChanging Epidemiological Trends of Hepatobiliary Carcinomas in Austria 2010-2018.
Not available
S-EPMC9264900 | biostudies-literature
UnknownThe impact of thyroid hormones on patients with hepatocellular carcinoma.
Not available
S-EPMC5542594 | biostudies-literature
UnknownVariation in both IL28B and KIR2DS3 genes influence pegylated interferon and ribavirin hepatitis C treatment outcome in HIV-1 co-infection.
Not available
S-EPMC3691248 | biostudies-literature
UnknownAssessing the periprocedural magnitude of platelet count change in response to lusutrombopag.
Not available
S-EPMC7887643 | biostudies-literature
UnknownErectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension.
Not available
S-EPMC6766949 | biostudies-literature
Sort   by:  
 Page size